• Palomid 529: A Precision Lens on ESCC Resistance

  2026-09-01

  Palomid 529 (P529) offers a dual mTORC1/mTORC2 approach for investigating PI3K/Akt/mTOR signaling in esophageal squamous cell carcinoma. This article focuses on assay design, causal interpretation, and how to connect RCN2-driven cisplatin resistance with tumor angiogenesis inhibition and radiotherapy enhancement.

• Ro 3306 for Reliable Cell-Cycle Assays

  2026-09-01

  Learn how Ro 3306, SKU A8885, can improve interpretation of cell-cycle, proliferation, viability, and DNA-repair experiments. This scenario-based guide covers mechanism, solvent handling, G2/M synchronization, assay controls, data interpretation, and practical product selection.

• Reactive Oxygen Species Assay Kit: Mechanism

  2026-08-31

  Explore how the Reactive Oxygen Species Assay Kit (DHE) converts intracellular superoxide into a mechanistically useful endpoint. This guide connects DHE fluorescence with the PINK1–Parkin mitophagy findings reported in pulmonary fibrosis research and explains how to interpret the assay rigorously.

• FKBP9, ER Stress, and Glioblastoma Malignancy

  2026-08-31

  Xu et al. identify FKBP9 as an ER-resident immunophilin that promotes glioblastoma growth, invasion, and tumor formation while protecting cells from ER stress. The study connects FKBP9 to ASK1–p38MAPK signaling and the IRE1α–XBP1 unfolded protein response, providing a mechanistic framework for studying stress-adapted GBM biology.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-30

  Song and colleagues show that murine norovirus exploits the membrane-rupture protein NINJ1 to release the viral immunomodulatory protein NS1 through an unconventional, caspase-3-dependent pathway. The study combines CRISPR screening, infection models, protein-interaction analysis, mutagenesis, and mouse experiments to connect selective viral secretion with enteric infection.

• IEM-1925 Against Soman-Induced Status Epilepticus

  2026-08-29

  A 2026 NeuroToxicology study examined IEM-1925 as a dual AMPA/NMDA glutamate receptor strategy for soman-induced status epilepticus, reporting coordinated seizure suppression, hippocampal protection, and improved behavioral outcomes in rats. Its main contribution is to connect acute electrographic seizure control with longer-term neurodegeneration and cognition endpoints, while highlighting limitations of transient benzodiazepine-based control.

• Panobinostat (LBH589): An ECM–Immune Assay Lens

  2026-08-28

  Panobinostat (LBH589) offers a powerful way to connect HDAC-dependent epigenetic regulation with macrophage–fibroblast extracellular-matrix remodeling. This article translates recent form-deprivation myopia findings into a rigorous assay framework while distinguishing pharmacological pathway effects from cell-type-specific causality.

• 10058-F4: Practical c-Myc-Max Inhibition Workflows

  2026-08-28

  10058-F4 enables time-controlled disruption of c-Myc/Max signaling in apoptosis assays, acute myeloid leukemia research, and prostate cancer models. This guide connects compound handling with target-engagement readouts, experimental controls, and a cautious extension toward APEX2–TERT studies.

• ECM Internalisation, p38β, and Cancer Cell Migration

  2026-08-27

  Martinez et al. developed a live-cell, high-content assay that revealed extracellular matrix internalisation as an active regulator of invasive carcinoma-cell migration. Their data connect α2β1 integrin, MAP3K1, MAPK11/p38β, PPP2R1A, and NHE1 to ECM uptake and lysosomal processing, creating a mechanistic framework for studying tumour invasion and pathway-directed experiments.

• HOXC8, Caspase-1, and Pyroptosis in Lung Tumors

  2026-08-27

  The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 in non-small cell lung carcinoma, linking HOXC8 loss to ASC-independent pyroptosis rather than conventional apoptotic death. Its genetic, pharmacological, transcriptional, and tumor-model evidence suggests that restoring caspase-1-driven cell death may be a useful strategy for understanding HOXC8-dependent lung tumorigenesis.

• From Gut Microbial Injury to RIP1 Biology

  2026-08-26

  A translational framework for using Necrostatin-1 to test whether microbial virulence, necroptosis, and tissue injury converge on RIP1 kinase signaling in inflammatory disease models.

• CD47 Inhibits Phagocytosis via Vav Dephosphorylation

  2026-08-26

  Miller et al. show that CD47 suppresses macrophage phagocytosis by blocking Vav phosphorylation downstream of Syk, thereby limiting Rac-dependent actin remodeling rather than preventing Vav recruitment or Syk activation. The study distinguishes Rac-based reaching from Rho-based sinking and identifies Vav as a mechanistic control point linking inhibitory CD47–SIRPα signaling to phagocytic behavior.

• Cycloheximide: Reading Protein Turnover in Cancer

  2026-08-25

  A mechanistic and translational guide to using Cycloheximide as a controlled protein biosynthesis inhibitor for dissecting cyclin D1 turnover, apoptosis, and model-specific therapeutic hypotheses.

• mTORC1 Oscillations Shape Cell-Cycle Progression

  2026-08-25

  Joshi et al. show that mTORC1 activity is not constant during proliferation: it is lowest in mitosis and G1 and highest during S and G2. Their results link this oscillation to interphase progression, Chk1/Wee1-dependent mitotic entry, and phase-specific sensitivity to autophagy induction.

• Tetrandrine: A Mechanistic Guide to Assay Design

  2026-08-24

  Tetrandrine is a versatile Tetrandrine alkaloid for calcium signaling, ion channel modulation studies, and disease-model research. This guide connects its physicochemical profile with rigorous assay design and explains what a SARS-CoV-2 NSP15 screening study can—and cannot—justify experimentally.

7056 records 1/471 page Next 12345 下5页 Last page